IDH1 and glioblastoma: Mutations in IDH1 and 2 are the fundamental hallmarks of brain cancers and they are reported up to ≥80% in WHO grade II/III astrocytomas, oligodendrogliomas, glioblastomas, and oligoastrocytomas [18].